We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current LIFE market cap is 128.73M. The company's latest EPS is USD -0.7437 and P/E is -2.55.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 353k | 0 | 235k |
| Operating Income | -12.79M | -13.56M | -12.62M | -15.96M | -16.64M |
| Net Income | -11.95M | -12.34M | -11.34M | -14.76M | -15.49M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 422k | 10.46M | 0 | 10.39M | 353k |
| Operating Income | -22.98M | -15.91M | -34.02M | -46.4M | -54.92M |
| Net Income | -23.6M | -16.22M | -33.77M | -45.34M | -50.39M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 136.84M | 132.75M | 125.07M | 120.65M | 113.25M |
| Total Liabilities | 27.14M | 26.7M | 26.87M | 30.18M | 28.97M |
| Total Equity | 109.7M | 106.05M | 98.2M | 90.47M | 84.28M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 36.19M | 38.73M | 115.54M | 95.79M | 120.65M |
| Total Liabilities | 15.16M | 7.24M | 6.41M | 24.5M | 30.18M |
| Total Equity | 21.03M | 31.48M | 109.13M | 71.28M | 90.47M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -590k | -12.6M | -22.16M | -33.22M | -22.38M |
| Investing | -38.17M | -42.33M | -37.95M | -20.13M | -1.36M |
| Financing | 49.5M | 57.51M | 60.2M | 66.23M | 7.73M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -20.01M | -15.3M | -33.08M | -41.89M | -33.22M |
| Investing | 4.93M | 6.9M | -91.57M | 47.25M | -20.13M |
| Financing | 1.34M | 16.14M | 110.03M | 5.45M | 66.23M |
| Market Cap | 128.73M |
| Price to Earnings Ratio | -2.55 |
| Price to Sales Ratio | 365.38 |
| Price to Cash Ratio | 5.71 |
| Price to Book Ratio | 1.42 |
| Dividend Yield | - |
| Shares Outstanding | 67.75M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.05 (2.56%) |
| Company Name | aTyr Pharma Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.atyrpharma.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
